Gene · 3163
Papers2,258
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,258
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative transcriptome and single-cell sequencing technology analysis of the potential therapeutic benefits of oleanolic acid in liver injury and liver cancer. | Aging (Albany NY) | 2023 | 38127054 | PubTator, text mining | PubMed |
| Oxidative stress drives vascular smooth muscle cell damage in acute Stanford type A aortic dissection through HIF-1α/HO-1 mediated ferroptosis. | Heliyon | 2023 | 38125409 | PubTator, text mining | PubMed |
| A Review of Synthesis and Applications of Al2O3 for Organic Dye Degradation/Adsorption. | Molecules | 2023 | 38067651 | PubTator, text mining | PubMed |
| A step toward autonomy in education: probing into the effects of practicing self-assessment, resilience, and creativity in task supported language learning. | BMC Psychol | 2023 | 38062504 | PubTator, text mining | PubMed |
| An enzyme that selectively S-nitrosylates proteins to regulate insulin signaling. | Cell | 2023 | 38056462 | Swiss-Prot, curated | PubMed |
| A glance through the effects of CD4+ T cells, CD8+ T cells, and cytokines on Alzheimer's disease. | Comput Struct Biotechnol J | 2023 | 38053545 | PubTator, text mining | PubMed |
| Activation of the Nrf-2/HO-1 signalling axis can alleviate metabolic syndrome in cardiovascular disease. | Ann Med | 2023 | 38039549 | PubTator, text mining | PubMed |
| Nanoscale Bilirubin Analysis in Translational Research and Precision Medicine by the Recombinant Protein HUG. | Int J Mol Sci | 2023 | 38003479 | PubTator, text mining | PubMed |
| A Review of the Potential of Nuclear Factor [Erythroid-Derived 2]-like 2 Activation in Autoimmune Diseases. | Brain Sci | 2023 | 38002492 | PubTator, text mining | PubMed |
| Ellagic Acid and Cancer Hallmarks: Insights from Experimental Evidence. | Biomolecules | 2023 | 38002335 | PubTator, text mining | PubMed |
| Heme Oxygenase-1 and Its Role in Colorectal Cancer. | Antioxidants (Basel) | 2023 | 38001842 | PubTator, text mining | PubMed |
| The Contribution of Hippocampal All-Trans Retinoic Acid (ATRA) Deficiency to Alzheimer's Disease: A Narrative Overview of ATRA-Dependent Gene Expression in Post-Mortem Hippocampal Tissue. | Antioxidants (Basel) | 2023 | 38001775 | PubTator, text mining | PubMed |
| Physicochemical Characterization and Oxidative Potential of Iron-Containing Particles Emitted from Xuanwei Coal Combustion. | Toxics | 2023 | 37999573 | PubTator, text mining | PubMed |
| The Pharmacological Effect of Hemin in Inflammatory-Related Diseases: Protocol for a Systematic Review. | JMIR Res Protoc | 2023 | 37971806 | PubTator, text mining | PubMed |
| Metabolic predictors of response to immune checkpoint blockade therapy. | iScience | 2023 | 37965137 | PubTator, text mining | PubMed |
| Menstrual blood-derived endometrial stem cell, a unique and promising alternative in the stem cell-based therapy for chemotherapy-induced premature ovarian insufficiency. | Stem Cell Res Ther | 2023 | 37957675 | PubTator, text mining | PubMed |
| Relative clause comprehension in Cantonese-speaking children with and without developmental language disorder. | PLoS One | 2023 | 37934774 | PubTator, text mining | PubMed |
| Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases. | Antioxidants (Basel) | 2023 | 37891890 | PubTator, text mining | PubMed |
| Rare variants with large effects provide functional insights into the pathology of migraine subtypes, with and without aura. | Nat Genet | 2023 | 37884687 | PubTator, text mining | PubMed |
| Olanzapine alters the expression of gasotransmitter-related enzymes: CBS and HO-2 in the rat hippocampus and striatum. | Pharmacol Rep | 2023 | 37874531 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3163/papers?page=6